Anzeige
Mehr »
Login
Freitag, 21.01.2022 Börsentäglich über 12.000 News von 667 internationalen Medien
East Africa Metals: Löst der UNO-Generalsekretär einen Kaufrausch in dieser Aktie aus?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3C311 ISIN: US33749P1012 Ticker-Symbol: 3660 
München
20.01.22
08:02 Uhr
1,192 Euro
-0,016
-1,34 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
FIRST WAVE BIOPHARMA INC Chart 1 Jahr
5-Tage-Chart
FIRST WAVE BIOPHARMA INC 5-Tage-Chart
RealtimeGeldBriefZeit
1,1651,18820.01.
1,1441,20920.01.

Aktuelle News zur FIRST WAVE BIOPHARMA Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
13.01.First Wave BioPharma Files Two Provisional US Patent Applications For Adrulipase-
13.01.First Wave BioPharma, Inc.: First Wave BioPharma Provides Update on Adrulipase (FW-EPI) Clinical Program-
07.01.First Wave BioPharma, Inc.: First Wave BioPharma Announces Further Adjournment of Annual Meeting2
FIRST WAVE BIOPHARMA Aktie jetzt für 0€ handeln
06.01.EXCLUSIVE: First Wave BioPharma CEO Talks COVID-19 Trial, Says 'If The Data Is Positive, I Think The Sky Is The Limit For Our Stock'2
06.01.First Wave BioPharma, Inc.: First Wave BioPharma Completes Enrollment for Part 2 of RESERVOIR Phase 2 Trial Evaluating FW-COV in COVID-19-Related GI Infections-
04.01.First Wave BioPharma, Inc.: First Wave BioPharma to Participate in Two Investor Conferences in January 20222
17.12.21First Wave BioPharma, Inc.: First Wave BioPharma Announces Adjournment of Annual Meeting1
13.12.21First Wave BioPharma, Inc. - 8-K, Current Report4
13.12.21First Wave BioPharma, Inc.: First Wave BioPharma Chairman and CEO Issues Letter to Shareholders2
09.12.21First Wave BioPharma, Inc.: First Wave BioPharma Names Brian Feagan, M.D., to Scientific Advisory Board2
06.12.21First Wave BioPharma, Inc. - 8-K, Current Report2
06.12.21First Wave BioPharma, Inc.: First Wave BioPharma's CEO and President, James Sapirstein, to Participate in CEO Panel Discussion at 2021 BioFlorida Conference2
30.11.21First Wave Bio jumps 41% on positive DMC recommendation on Phase 2 Reservoir trial in COVID-1925
30.11.21First Wave BioPharma Stock Jumps On Niclosamide's Favorable Safety Profile In COVID-19 Related GI Infections6
30.11.21First Wave BioPharma Says Independent DMC Recommends Part 2 COVID-19 RESERVOIR Study Of Niclosamide16
29.11.21First Wave BioPharma, Inc. - 8-K, Current Report4
16.11.21First Wave BioPharma, Inc. - 10-Q/A, Quaterly Report4
09.11.21First Wave BioPharma, Inc. - 8-K, Current Report4
21.10.21First Wave BioPharma, Inc.: First Wave BioPharma Forms Steering Committee for Phase 2a PASSPORT Clinical Trial to Evaluate FW-ICI-AC in Cancer Patients ...6
20.10.21ME, CYCN and FWBI among pre market gainers3
Seite:  Weiter >>
71 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1